Clinical Data on Mallinckrodt Pharmaceuticals' H.P. Acthar Gel to be Unveiled at American College of Rheumatology

By: via Benzinga
Mallinckrodt plc (NYSE: MNK), a leading specialty biopharmaceutical company, today announced that data from a pilot study for its H.P. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.